查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1417393

全球内视镜逆行性造影(ERCP) 市场：趋势、预测与竞争分析（~2030 年）

Endoscopic Retrograde Cholangiopancreatography Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

内视镜逆行性造影的趋势与预测

至2030年，全球内视镜逆行性造影市场规模预计将达19亿美元，2024年至2030年复合年增长率为5.5%。该市场的主要驱动力是癌症发病率上升、对微创手术/手术的日益偏好以及政府和医疗机构不断增加的财务承诺。全球内视镜逆行性造影市场的未来充满希望，医院和门诊手术中心/诊所市场充满机会。

内视镜逆行性造影市场洞察

Lucintel 预测，由于胃肠道疾病的盛行率不断增加，内视镜治疗设备在预测期内仍将是最大的细分市场。

在这个市场中，医院可能仍然是最大的细分市场，因为这些设施中提供了广泛的 ERCP 设备。

由于癌症患者数量的增加和先进 ERCP 工具的引入，在预测期内，北美可能仍然是最大的地区。

常问问题

Q1.市场规模有多大？

A1. 到 2030 年，全球内视镜逆行性造影市场预计将达到 19 亿美元。

Q2.市场成长预测如何？

A2. 2024年至2030年，全球内视镜逆行性造影市场预计将以5.5%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素有哪些？

A3. 该市场的主要驱动力是癌症发病率上升、对微创手术和手术的日益偏好以及政府和医疗机构不断增加的财政承诺。

Q4.市场的主要细分市场是什么？

A4. 内视镜逆行性造影市场的未来前景广阔，医院和门诊手术中心/诊所市场充满机会。

Q5.市场上主要企业有哪些？

A5. 进行内视镜逆行性造影的主要企业如下。

  • Hobbs Medical
  • STERIS
  • Merit Medical Systems
  • TeleMed Systems
  • Changzhou Health Microport Medical Device

Q6.未来最大的细分市场是什么？

A6.Lucintel 预计，由于胃肠道疾病的盛行率不断增加，内视镜治疗设备在预测期内仍将是其最大的细分市场。

Q7. 未来五年预计哪个地区将成为最大的市场？

A7. 由于癌症患者的增加和先进的 ERCP 工具的引入，在预测期内，北美将继续成为最大的地区。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球内视镜逆行性胰造影市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 市场趋势及预测分析（2018-2030）

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球内视镜逆行性造影市场趋势（2018-2023）与预测（2024-2030）
  • 全球内视镜逆行性胰造影市场：副产品
    • 内视镜
    • 内视镜治疗装置
    • 视觉化系统
    • 能源装置
    • 其他的
  • 全球内视镜逆行性胰造影市场：依程序
    • 胆管括约肌切开术
    • 胆道置入术
    • 胆道透析
    • 胰臟括约肌切开术
    • 胰管支架置入术
    • 胰管扩张
  • 全球内视镜逆行性胰造影市场：依最终用途分类
    • 医院
    • 门诊手术中心/诊所
    • 其他的

第四章市场趋势与预测分析：按地区（2018-2030）

  • 全球内视镜逆行性造影市场（按地区）
  • 北美洲
  • 欧洲
  • 亚太地区
  • 其他地区

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 副产品
    • 按程式
    • 按最终用途
    • 按地区
  • 全球内视镜逆行性造影市场的新趋势
  • 战略分析
    • 新产品开发
    • 全球内视镜逆行性造影市场的产能扩张
    • 全球内视镜逆行性造影市场的合併、收购及合资企业
    • 认证和许可

第七章主要企业概况

  • Hobbs Medical
  • STERIS
  • Merit Medical Systems
  • TeleMed Systems
  • Changzhou Health Microport Medical Device
简介目录

Endoscopic Retrograde Cholangiopancreatography Trends and Forecast

The future of the global endoscopic retrograde cholangiopancreatography market looks promising with opportunities in the hospital and ambulatory surgery center & clinic markets. The global endoscopic retrograde cholangiopancreatography market is expected to reach an estimated $1.9 billion by 2030 with a CAGR of 5.5% from 2024 to 2030. The major drivers for this market are elevated cancer rates, increasing inclination towards minimally invasive procedures and surgeries, and growing financial commitments from governments and healthcare institutions.

A more than 150-page report is developed to help in your business decisions.

Endoscopic Retrograde Cholangiopancreatography by Segment

The study includes a forecast for the global endoscopic retrograde cholangiopancreatography by product, procedure, end use, and region.

Endoscopic Retrograde Cholangiopancreatography Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Endoscopes
  • Endotherapy Devices
  • Visualization Systems
  • Energy Devices
  • Others

Endoscopic Retrograde Cholangiopancreatography Market by Procedure [Shipment Analysis by Value from 2018 to 2030]:

  • Biliary Sphincterotomy
  • Biliary Stenting
  • Biliary Dialtation
  • Pancreatic Sphincterotomy
  • Pancreatic Duct Stenting
  • Pancreatic Duct Dilatation

Endoscopic Retrograde Cholangiopancreatography Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Ambulatory Surgery Centers & Clinics
  • Other

Endoscopic Retrograde Cholangiopancreatography Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Endoscopic Retrograde Cholangiopancreatography Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies endoscopic retrograde cholangiopancreatography companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the endoscopic retrograde cholangiopancreatography companies profiled in this report include-

  • Hobbs Medical
  • STERIS
  • Merit Medical Systems
  • TeleMed Systems
  • Changzhou Health Microport Medical Device

Endoscopic Retrograde Cholangiopancreatography Market Insights

Lucintel forecasts that endotherapy device will remain the largest segment over the forecast period due to growing incidence of gastrointestinal disorders.

Within this market, hospital will remain the largest segment due to availability of wide range of ERCP devices in these facilities.

North America will remain the largest region over the forecast period due to rising frequency of cancer cases and introduction of advanced ERCP tools in the region.

Features of the Global Endoscopic Retrograde Cholangiopancreatography Market

Market Size Estimates: Endoscopic retrograde cholangiopancreatography market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Endoscopic retrograde cholangiopancreatography market size by product, procedure, end use, and region in terms of value ($B).

Regional Analysis: Endoscopic retrograde cholangiopancreatography market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, procedures, end uses, and regions for the endoscopic retrograde cholangiopancreatography market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the endoscopic retrograde cholangiopancreatography market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the endoscopic retrograde cholangiopancreatography market size?

Answer: The global endoscopic retrograde cholangiopancreatography market is expected to reach an estimated $1.9 billion by 2030.

Q2. What is the growth forecast for endoscopic retrograde cholangiopancreatography market?

Answer: The global endoscopic retrograde cholangiopancreatography market is expected to grow with a CAGR of 5.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the endoscopic retrograde cholangiopancreatography market?

Answer: The major drivers for this market are elevated cancer rates, increasing inclination towards minimally invasive procedures and surgeries, and growing financial commitments from governments and healthcare institutions.

Q4. What are the major segments for endoscopic retrograde cholangiopancreatography market?

Answer: The future of the endoscopic retrograde cholangiopancreatography market looks promising with opportunities in the hospital and ambulatory surgery center & clinic markets.

Q5. Who are the key endoscopic retrograde cholangiopancreatography market companies?

Answer: Some of the key endoscopic retrograde cholangiopancreatography companies are as follows.

  • Hobbs Medical
  • STERIS
  • Merit Medical Systems
  • TeleMed Systems
  • Changzhou Health Microport Medical Device

Q6. Which endoscopic retrograde cholangiopancreatography market segment will be the largest in future?

Answer: Lucintel forecasts that endotherapy device will remain the largest segment over the forecast period due to growing incidence of gastrointestinal disorders.

Q7. In endoscopic retrograde cholangiopancreatography market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to rising frequency of cancer cases and introduction of advanced ERCP tools in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the endoscopic retrograde cholangiopancreatography market by product (endoscopes, endotherapy devices, visualization systems, energy devices, and others), procedure (biliary sphincterotomy, biliary stenting, biliary dialtation, pancreatic sphincterotomy, pancreatic duct stenting, and pancreatic duct dilatation), end use (hospitals, ambulatory surgery centers & clinics, and other), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Endoscopic Retrograde Cholangiopancreatography Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Endoscopic Retrograde Cholangiopancreatography Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Endoscopic Retrograde Cholangiopancreatography Market by Product
    • 3.3.1: Endoscopes
    • 3.3.2: Endotherapy Devices
    • 3.3.3: Visualization Systems
    • 3.3.4: Energy Devices
    • 3.3.5: Others
  • 3.4: Global Endoscopic Retrograde Cholangiopancreatography Market by Procedure
    • 3.4.1: Biliary Sphincterotomy
    • 3.4.2: Biliary Stenting
    • 3.4.3: Biliary Dialtation
    • 3.4.4: Pancreatic Sphincterotomy
    • 3.4.5: Pancreatic Duct Stenting
    • 3.4.6: Pancreatic Duct Dilatation
  • 3.5: Global Endoscopic Retrograde Cholangiopancreatography Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Ambulatory Surgery Centers & Clinics
    • 3.5.3: Other

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Endoscopic Retrograde Cholangiopancreatography Market by Region
  • 4.2: North American Endoscopic Retrograde Cholangiopancreatography Market
    • 4.2.2: North American Endoscopic Retrograde Cholangiopancreatography Market by End Use: Hospitals, Ambulatory Surgery Centers & Clinics, and Other
  • 4.3: European Endoscopic Retrograde Cholangiopancreatography Market
    • 4.3.1: European Endoscopic Retrograde Cholangiopancreatography Market by Product: Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices, and Others
    • 4.3.2: European Endoscopic Retrograde Cholangiopancreatography Market by End Use: Hospitals, Ambulatory Surgery Centers & Clinics, and Other
  • 4.4: APAC Endoscopic Retrograde Cholangiopancreatography Market
    • 4.4.1: APAC Endoscopic Retrograde Cholangiopancreatography Market by Product: Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices, and Others
    • 4.4.2: APAC Endoscopic Retrograde Cholangiopancreatography Market by End Use: Hospitals, Ambulatory Surgery Centers & Clinics, and Other
  • 4.5: ROW Endoscopic Retrograde Cholangiopancreatography Market
    • 4.5.1: ROW Endoscopic Retrograde Cholangiopancreatography Market by Product: Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices, and Others
    • 4.5.2: ROW Endoscopic Retrograde Cholangiopancreatography Market by End Use: Hospitals, Ambulatory Surgery Centers & Clinics, and Other

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Endoscopic Retrograde Cholangiopancreatography Market by Product
    • 6.1.2: Growth Opportunities for the Global Endoscopic Retrograde Cholangiopancreatography Market by Procedure
    • 6.1.3: Growth Opportunities for the Global Endoscopic Retrograde Cholangiopancreatography Market by End Use
    • 6.1.4: Growth Opportunities for the Global Endoscopic Retrograde Cholangiopancreatography Market by Region
  • 6.2: Emerging Trends in the Global Endoscopic Retrograde Cholangiopancreatography Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Endoscopic Retrograde Cholangiopancreatography Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Endoscopic Retrograde Cholangiopancreatography Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Hobbs Medical
  • 7.2: STERIS
  • 7.3: Merit Medical Systems
  • 7.4: TeleMed Systems
  • 7.5: Changzhou Health Microport Medical Device